Ying Luo

This inventor holds 34 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in Cell Cycle Proteins. Top assignees: Rigel Pharmaceuticals, Incorporated, Shanghai Genomics, Inc., Intel Corporation. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Luo. Retrieved from https://idiyas.com/inventor/ying-luo-98rbiwc8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 7)

% Patents Active = 79.4

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 188(Granted Patents)

Location History:

Los Altos, CA (US) (1999 - 2009)
Shanghai, CN (2006 - 2023)

Company Filing History:

26 out of 492

Rigel Pharmaceuticals, Incorporated

patents

3 out of 6

Shanghai Genomics, Inc.

Shanghai Ic R&d Center Co., Ltd

patents

5. 1 out of 16

Chengdu Image Design Technology Co., Ltd.

patents

6. 1 out of 63

Clontech Laboratories, Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Viewport Switch Latency

Immersive Video

Motion Detection Circuit

Kinase Inhibitors

Apoptosis Proteins

Tumor Marker

Cell Cycle Proteins

Shuttle Vectors

Exocytotic Proteins

Mammalian Protein Interaction

DNA Sequence Transfer

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12652433 - Viewport switch latency reduction in live streaming (2026-06-09),

2. 12418634 - Real-time adaptive correction in viewport prediction for improved immersive video (2025-09-16),

3. 11611813 - Method of removing fixed pattern noise (2023-03-21),

4. 11102380 - Motion detection circuit and motion detection method applied to CIS (2021-08-24),

5. 8309550 - Kinase inhibitors and their use as pharmaceutical agents (2012-11-13),

6. 7488805 - Apoptosis proteins (2009-02-10),

7. 7485621 - Tumor tag and the use thereof (2009-02-03),

8. 7462704 - Tumor marker and its use (2008-12-09),

9. 7423118 - IAPS associated cell cycle proteins, compositions and methods of use (2008-09-09),

10. 7420045 - IAPs associated cell cycle proteins, compositions and methods of use (2008-09-02),

11. 7384761 - Methods of identifying an agent capable of interfering with Rad9 dephosphorylation (2008-06-10),

12. 7300780 - Germinal center kinase proteins, compositions, and methods of use (2007-11-27),

13. 7265214 - Germinal center kinase proteins, compositions and methods of use (2007-09-04),

14. 7223850 - Apoptosis proteins (2007-05-29),

15. 7122630 - SYK-UBP polypeptides and methods of making and isolating same (2006-10-17),

Title: The Innovative Journey of Inventor Ying Luo

Introduction: Ying Luo, a pioneering inventor hailing from Shanghai, China, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Ying Luo's most recent patents include advancements in artificial intelligence algorithms for autonomous vehicles, smart home technology for energy efficiency, and wearable health monitoring devices.

Career Highlights: With a career spanning over two decades, Ying Luo has established himself as a leading figure in the tech industry. He has worked with renowned companies such as Huawei and Tencent, where he spearheaded research and development projects that have shaped the future of technology.

Collaborations: Throughout his career, Ying Luo has collaborated with top researchers and engineers from prestigious universities and research institutions worldwide. His collaborative efforts have led to the creation of innovative solutions that have revolutionized various sectors.

Conclusion: Ying Luo's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of inventors and shape the technological landscape for years to come.

Profile summary based on public USPTO records.